DETAILS, FICTION AND HEMGENIX

Range of suitable people: CDEC mentioned the uncertainty in the amount of individuals with moderately serious to serious hemophilia B in Canada eligible for etranacogene dezaparvovec. Scientific experts consulted by CADTH indicated that some people who will be labeled as acquiring moderate or reasonable condition might have a serious bleeding pheno